Atlantic Union Bankshares Corp Abbott Laboratories Transaction History

Atlantic Union Bankshares Corp

$1.62 Billion
Q3 2024

A detailed history of Atlantic Union Bankshares Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Atlantic Union Bankshares Corp holds 95,159 shares of ABT stock, worth $11.1 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

95,159

Previous 100,109 4.94%

Holding current value

$11.1 Million

Previous $10.4 Million 4.3%

% of portfolio

0.67%

Previous 0.68%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $495,346 - $584,743	-4,950 Reduced 4.94%	95,159 $10.8 Million
Q2 2024 Jul 24, 2024	BUY	$100.73 - $112.44 $3.22 Million - $3.6 Million	32,012 Added 47.01%	100,109 $10.4 Million
Q1 2024 Apr 16, 2024	SELL	$109.52 - $120.96 $295,594 - $326,471	-2,699 Reduced 3.81%	68,097 $7.74 Million
Q4 2023 Jan 19, 2024	SELL	$90.19 - $110.4 $681,295 - $833,961	-7,554 Reduced 9.64%	70,796 $7.79 Million
Q3 2023 Oct 20, 2023	SELL	$95.53 - $114.62 $591,330 - $709,497	-6,190 Reduced 7.32%	78,350 $7.59 Million
Q2 2023 Jul 11, 2023	SELL	$100.78 - $112.29 $1.47 Million - $1.64 Million	-14,629 Reduced 14.75%	84,540 $9.22 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $600,338 - $706,633	-6,198 Reduced 5.88%	99,169 $10 Million
Q4 2022 Feb 09, 2023	SELL	$95.06 - $111.52 $782,533 - $918,032	-8,232 Reduced 7.25%	105,367 $11.6 Million
Q3 2022 Oct 25, 2022	SELL	$96.76 - $112.03 $1.1 Million - $1.28 Million	-11,393 Reduced 9.11%	113,599 $11 Million
Q2 2022 Jul 21, 2022	SELL	$102.07 - $123.37 $62,466 - $75,502	-612 Reduced 0.49%	124,992 $13.6 Million
Q1 2022 Apr 26, 2022	BUY	$114.02 - $139.04 $123,027 - $150,024	1,079 Added 0.87%	125,604 $14.9 Million
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $57,302 - $70,164	-496 Reduced 0.4%	124,525 $17.5 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $192,955 - $213,465	-1,654 Reduced 1.31%	125,021 $14.8 Million
Q2 2021 Jul 26, 2021	SELL	$105.79 - $124.53 $271,033 - $319,045	-2,562 Reduced 1.98%	126,675 $14.7 Million
Q1 2021 May 04, 2021	SELL	$108.84 - $128.23 $58,229 - $68,603	-535 Reduced 0.41%	129,237 $15.5 Million
Q4 2020 Feb 01, 2021	SELL	$105.0 - $114.42 $351,015 - $382,506	-3,343 Reduced 2.51%	129,772 $14.2 Million
Q3 2020 Oct 16, 2020	SELL	$91.64 - $111.29 $222,776 - $270,545	-2,431 Reduced 1.79%	133,115 $14.5 Million
Q2 2020 Jul 15, 2020	BUY	$76.57 - $98.0 $70,061 - $89,670	915 Added 0.68%	135,546 $12.4 Million
Q1 2020 Apr 10, 2020	BUY	$62.82 - $91.86 $606,904 - $887,459	9,661 Added 7.73%	134,631 $10.6 Million
Q4 2019 Jan 14, 2020	SELL	$78.51 - $87.4 $78,274 - $87,137	-997 Reduced 0.79%	124,970 $10.9 Million
Q3 2019 Oct 17, 2019	SELL	$81.84 - $88.74 $480,482 - $520,992	-5,871 Reduced 4.45%	125,967 $10.5 Million
Q2 2019 Jul 23, 2019	BUY	$72.88 - $85.0 $5.13 Million - $5.98 Million	70,324 Added 114.32%	131,838 $11.1 Million
Q1 2019 Apr 10, 2019	SELL	$66.22 - $80.06 $394,273 - $476,677	-5,954 Reduced 8.82%	61,514 $4.92 Million
Q4 2018 Jan 14, 2019	SELL	$65.56 - $74.27 $47,465 - $53,771	-724 Reduced 1.06%	67,468 $4.88 Million
Q3 2018 Oct 11, 2018	SELL	$60.81 - $73.36 $73,944 - $89,205	-1,216 Reduced 1.75%	68,192 $5 Million
Q2 2018 Jul 12, 2018	SELL	$57.57 - $63.54 $176,336 - $194,623	-3,063 Reduced 4.23%	69,408 $4.23 Million
Q1 2018 Apr 11, 2018	SELL	$56.27 - $63.62 $122,443 - $138,437	-2,176 Reduced 2.92%	72,471 $4.34 Million
Q4 2017 Jan 10, 2018	SELL	$53.68 - $57.47 $94,691 - $101,377	-1,764 Reduced 2.31%	74,647 $4.26 Million
Q3 2017 Oct 13, 2017	BUY	$48.06 - $53.64 $3.67 Million - $4.1 Million	76,411	76,411 $4.08 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Union Bankshares Corp, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Union Bankshares Corp with notifications on news.

Account

Atlantic Union Bankshares Corp Abbott Laboratories Transaction History